Most bought healthcare stocks in Q2 2024
See which Healthcare stocks institutional investors increased the most in Q2 2024, measured as net growth in reported share positions from Q1 2024 into Q2 2024. Notable additions at the top of this list include CVS HEALTH CORP (CVS), HUMANA INC (HUM), SOLVENTUM CORP (SOLV), BAXTER INTERNATIONAL INC (BAX). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 29,199,944 | $664.40M | 1 | 11 | 7 | 3 | 19 |
| HUM | HUMANA INC | 8,592,294 | $3.16B | 2 | 4 | 5 | 1 | 11 |
| SOLV | SOLVENTUM CORP | 7,365,514 | $293.34M | 10 | 0 | 0 | 0 | 10 |
| BAX | BAXTER INTERNATIONAL INC | 5,674,647 | -$322.57M | 0 | 5 | 5 | 1 | 12 |
| ALHC | ALIGNMENT HEALTHCARE INC | 4,205,949 | $43.37M | 1 | 1 | 0 | 0 | 2 |
| PFE | PFIZER INC | 3,911,689 | $225.66M | 1 | 11 | 10 | 0 | 24 |
| RXRX | RECURSION PHARMACEUTICALS-A | 3,550,857 | -$34.20M | 0 | 1 | 1 | 0 | 3 |
| TXG | 10X GENOMICS INC-CLASS A | 3,174,786 | -$51.47M | 0 | 3 | 2 | 0 | 5 |
| WRBY | WARBY PARKER INC-CLASS A | 3,172,998 | $79.75M | 1 | 2 | 1 | 0 | 4 |
| UNH | UNITEDHEALTH GROUP INC | 3,075,735 | $1.77B | 6 | 17 | 16 | 0 | 43 |
| XRAY | DENTSPLY SIRONA INC | 3,002,053 | $7.48M | 0 | 2 | 3 | 0 | 5 |
| FTRE | FORTREA HOLDINGS INC | 2,803,327 | $4.49M | 0 | 2 | 2 | 1 | 4 |
| AVTR | AVANTOR INC | 2,472,263 | -$279.92M | 1 | 3 | 5 | 0 | 11 |
| HLN | HALEON PLC-ADR | 2,459,514 | -$1.69M | 0 | 3 | 3 | 0 | 8 |
| ABSI | ABSCI CORP | 2,096,494 | -$1.66M | 0 | 1 | 0 | 1 | 1 |
| NVST | ENVISTA HOLDINGS CORP | 2,011,994 | -$5.95M | 0 | 3 | 2 | 0 | 5 |
| DOCS | DOXIMITY INC-CLASS A | 1,976,788 | $96.70M | 0 | 2 | 2 | 1 | 4 |
| LFST | LIFESTANCE HEALTH GROUP INC | 1,934,423 | -$2.27M | 0 | 1 | 1 | 0 | 2 |
| INBX | INHIBRX BIOSCIENCES INC | 1,787,705 | $25.33M | 1 | 0 | 0 | 0 | 1 |
| BMY | BRISTOL-MYERS SQUIBB CO | 1,664,793 | -$386.08M | 3 | 5 | 9 | 1 | 21 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 1,574,097 | $54.30M | 0 | 2 | 0 | 0 | 2 |
| SGMO | SANGAMO THERAPEUTICS INC | 1,528,600 | $1.48M | 0 | 1 | 0 | 0 | 1 |
| ACHC | ACADIA HEALTHCARE CO INC | 1,517,387 | $54.67M | 0 | 3 | 1 | 0 | 4 |
| CRBU | CARIBOU BIOSCIENCES INC | 1,482,900 | $2.43M | 1 | 0 | 0 | 0 | 1 |
| GOSS | GOSSAMER BIO INC | 1,395,000 | $1.84M | 0 | 2 | 0 | 0 | 2 |
| ALLO | ALLOGENE THERAPEUTICS INC | 1,351,406 | $4.07M | 1 | 1 | 0 | 0 | 2 |
| BAYRY | BAYER AG-SPONSORED ADR | 1,275,315 | $7.06M | 0 | 1 | 0 | 0 | 1 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 949,921 | $20.26M | 0 | 2 | 0 | 0 | 3 |
| NVAX | NOVAVAX INC | 935,483 | $13.82M | 1 | 1 | 1 | 0 | 4 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 821,156 | $3.87M | 0 | 1 | 0 | 0 | 3 |
| INSM | INSMED INC | 815,883 | $67.07M | 1 | 0 | 0 | 2 | 1 |
| BDX | BECTON DICKINSON AND CO | 787,540 | $220.28M | 0 | 7 | 5 | 0 | 14 |
| GERN | GERON CORP | 781,723 | $3.31M | 1 | 0 | 0 | 0 | 1 |
| EVH | EVOLENT HEALTH INC - A | 769,801 | -$28.33M | 0 | 1 | 0 | 1 | 1 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 752,419 | -$338.76M | 2 | 8 | 5 | 1 | 15 |
| BIO | BIO-RAD LABORATORIES-A | 724,683 | $150.27M | 0 | 4 | 3 | 0 | 7 |
| VREX | VAREX IMAGING CORP | 707,304 | $7.33M | 1 | 2 | 1 | 0 | 4 |
| GLYC | GLYCOMIMETICS INC | 685,151 | $232.42K | 0 | 1 | 0 | 0 | 1 |
| LH | LABCORP HOLDINGS INC | 684,094 | $139.22M | 9 | 0 | 0 | 0 | 9 |
| ITGR | INTEGER HOLDINGS CORP | 683,380 | $78.75M | 0 | 1 | 0 | 0 | 1 |
| MRVI | MARAVAI LIFESCIENCES HLDGS-A | 668,552 | $27.76M | 0 | 1 | 0 | 0 | 1 |
| NTLA | INTELLIA THERAPEUTICS INC | 646,362 | -$41.91M | 2 | 2 | 0 | 0 | 4 |
| MRNS | MARINUS PHARMACEUTICALS INC | 621,625 | $727.30K | 1 | 0 | 0 | 0 | 1 |
| LBPH | LONGBOARD PHARMACEUTICALS IN | 606,934 | $23.66M | 1 | 1 | 0 | 1 | 2 |
| ADMA | ADMA BIOLOGICS INC | 567,826 | $29.33M | 0 | 1 | 1 | 0 | 2 |
| IMVT | IMMUNOVANT INC | 560,130 | $13.05M | 0 | 2 | 0 | 0 | 2 |
| FATE | FATE THERAPEUTICS INC | 548,544 | $1.29M | 1 | 0 | 0 | 0 | 3 |
| OSCR | OSCAR HEALTH INC - CLASS A | 547,168 | $64.66M | 0 | 3 | 3 | 0 | 6 |
| HUMA | HUMACYTE INC | 524,600 | $2.88M | 0 | 1 | 0 | 0 | 1 |
| TEM | TEMPUS AI INC | 522,698 | $18.29M | 1 | 0 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q2 2024
What are the most bought Healthcare stocks in Q2 2024?
The most bought healthcare stocks in Q2 2024 are those with the largest increase in reported share counts across institutional investors compared to Q1 2024, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q2 2024?
Among filers in this sector, net additions were largest in companies such as CVS HEALTH CORP (CVS), HUMANA INC (HUM), SOLVENTUM CORP (SOLV), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2024).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.